Cargando…
A designer hyper interleukin 11 (H11) is a biologically active cytokine
BACKGROUND: Interleukin 11 (IL-11) is a pleiotropic cytokine with anti-apoptotic, anti-inflammatory and hematopoietic potential. The IL-11 activity is determined by the expression of the IL-11R receptor alpha (IL-11Rα) and the signal transducing subunit β (gp130) on the cell membrane. A recombinant...
Autores principales: | Dams-Kozlowska, Hanna, Gryska, Katarzyna, Kwiatkowska-Borowczyk, Eliza, Izycki, Dariusz, Rose-John, Stefan, Mackiewicz, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382428/ https://www.ncbi.nlm.nih.gov/pubmed/22433466 http://dx.doi.org/10.1186/1472-6750-12-8 |
Ejemplares similares
-
Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2013) -
Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2016) -
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018) -
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
por: Gąbka-Buszek, Agnieszka, et al.
Publicado: (2020) -
Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model
por: Mackiewicz, Jacek, et al.
Publicado: (2015)